相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Combined Inhibition of MEK and Mammalian Target of Rapamycin Abolishes Phosphorylation of Cyclin-Dependent Kinase 4 in Glioblastoma Cell Lines and Prevents Their Proliferation
Sabine Paternot et al.
CANCER RESEARCH (2009)
TORC-Specific Phosphorylation of Mammalian Target of Rapamycin (mTOR): Phospho-Ser2481 Is a Marker for Intact mTOR Signaling Complex 2
Jeremy Copp et al.
CANCER RESEARCH (2009)
Role of the Novel mTOR Inhibitor RAD001 (Everolimus) in Anaplastic Thyroid Cancer
C. Papewalis et al.
HORMONE AND METABOLIC RESEARCH (2009)
Novel Oncogenic Actions of TRβ Mutants in Tumorigenesis
Celine J. Guigon et al.
IUBMB LIFE (2009)
Advances in Chemotherapy of Differentiated Epithelial and Medullary Thyroid Cancers
Steven I. Sherman
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer
C. J. Guigon et al.
ONCOGENE (2009)
Mammalian target of rapamycin is the key effector of phosphatidylinositol-3-OH-initiated proliferative signals in the thyroid follicular epithelium
Nicole Yeager et al.
CANCER RESEARCH (2008)
PTEN loss does not predict for response to RAD001 (everolimus) in a glioblastoma orthotopic xenograft test panel
Lin Yang et al.
CLINICAL CANCER RESEARCH (2008)
Targeting the PI3K-AKT-mTOR pathway: progress, pitfalls, and promises
Timothy A. Yap et al.
CURRENT OPINION IN PHARMACOLOGY (2008)
Regulation of β-catenin by a novel nongenomic action of thyroid hormone β receptor
Celine J. Guigon et al.
MOLECULAR AND CELLULAR BIOLOGY (2008)
Inhibition of phosphatidylinositol 3-kinase delays tumor progression and blocks metastatic spread in a mouse model of thyroid cancer
Fumihiko Furuya et al.
CARCINOGENESIS (2007)
The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas
Eva Hernando et al.
NATURE MEDICINE (2007)
Rapamycin derivatives reduce mTORC2 signaling and inhibit AKT activation in AML
Zhihong Zeng et al.
BLOOD (2007)
PDGFRs are critical for PI3K/Akt activation and negatively regulated by mTOR
Hongbing Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
A novel mechanism for Bcr-Abl action: Bcr-Abl-mediated induction of the eIF4F translation initiation complex and mRNA translation
S. Prabhu et al.
ONCOGENE (2007)
Pten loss in the mouse thyroid causes goiter and follicular adenomas:: Insights into thyroid function and Cowden disease pathogenesis
Nicole Yeager et al.
CANCER RESEARCH (2007)
Aberrant accumulation of PTTG1 induced by a mutated thyroid hormone β receptor inhibits mitotic progression
Hao Ying et al.
JOURNAL OF CLINICAL INVESTIGATION (2006)
mTOR and cancer: insights into a complex relationship
David M. Sabatini
NATURE REVIEWS CANCER (2006)
PPARγ insufficiency promotes follicular thyroid carcinogenesis via activation of the nuclear factor-κB signaling pathway
Y Kato et al.
ONCOGENE (2006)
Future directions in the treatment of hormone-sensitive advanced breast cancer: The RAD001 (everolimus)-letrozole clinical program
Heidi A. Lane et al.
SEMINARS IN ONCOLOGY (2006)
Activation of phosphatidylinositol 3-kinase signaling by a mutant thyroid hormone β receptor
F Furuya et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt
KE O'Reilly et al.
CANCER RESEARCH (2006)
Distinct specificities of pRb phosphorylation by CDK4 activated by cyclin D1 or cyclin D3 - Differential involvement in the distinct mitogenic modes of thyroid epithelial cells
S Paternot et al.
CELL CYCLE (2006)
AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma
CS Kim et al.
ENDOCRINOLOGY (2005)
Antitumor efficacy of intermittent treatment schedules with the rapamycin derivative RAD001 correlates with prolonged inactivation of ribosomal protein S6 kinase 1 in peripheral blood mononuclear cells
A Boulay et al.
CANCER RESEARCH (2004)
The TOR pathway: A target for cancer therapy
MA Bjornsti et al.
NATURE REVIEWS CANCER (2004)
Increased expression of phosphorylated p70S6 kinase and akt in papillary thyroid cancer tissues
M Miyakawa et al.
ENDOCRINE JOURNAL (2003)
Mice with a mutation in the thyroid hormone receptor β gene spontaneously develop thyroid carcinoma:: A mouse model of thyroid carcinogenesis
H Suzuki et al.
THYROID (2002)
Nitric oxide-induced cytostasis and cell cycle arrest of a human breast cancer cell line (MDA-MB-231): Potential role of cyclin D1
S Pervin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Mice with a targeted mutation in the thyroid hormone β receptor gene exhibit impaired growth and resistance to thyroid hormone
M Kaneshige et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
分享论文
